Diazyme Laboratories, Inc. Acquires Alfa Wassermann Diagnostic Technologies LLC.POWAY, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. announced today that it has acquired the business of Alfa Wassermann Diagnostic Technologies LLC. (AWDT) from CARR Biosystems. AWDT is an FDA registered manufacturer and seller of chemistry systems and reagents. Founded in 1960 and headquartered in West Caldwell, New Jersey, AWDT’s business will be integrated into Diazyme’s operations.
Diazyme Laboratories, Inc. Announces FDA 510(k) Clearance for Lipoprotein(a) Molarity AssayPOWAY, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Diazyme Lipoprotein(a) Molarity Assay. This clearance enables clinical laboratories to use the assay for the quantitative determination of lipoprotein-Lp(a) levels in human serum and plasma, reported in molar units (nmol/L).
